This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. . Marketing authorisation of icosapent ethyl comes after a decade of designing and conducting evidence-based cardiovascular clinical outcomes research.
Velocity is proud to unveil another groundbreaking initiative: the Cardiology Council to Accelerate Research Excellence (CARE). Learn more about the Cardiology CARE Council at velocityclinical.com/cardiology-care-council. Heart disease remains the leading cause of death worldwide.
Emergency visits for stroke are elevated after a heatwave, according to research presented today at ESC Asia, a scientific congress organized by the European Society of Cardiology (ESC), the Asian Pacific Society of Cardiology (APSC), and the Asean Federation of Cardiology (AFC).
Douglas is the Ursula Geller Professor of Research in Cardiovascular Diseases at Duke University and a past president of both the American College of Cardiology and the American Society of Echocardiography. The Grand Rounds session will be held on Friday, January 19, 2024, at 1:00 pm eastern. Join the online meeting.
James and Oldgren are professors of cardiology in the Department of Medical Sciences and the Uppsala Clinical Research Center at Uppsala University. Join the online meeting. The post June 12, 2024: Registry-Based DAPA-MI Trial to Be Featured in This Week’s PCT Grand Rounds appeared first on Rethinking Clinical Trials.
People who suffer from insomnia were 69% more likely to have a heart attack compared to those who didn't have the sleep disorder during an average nine years of follow-up, according to new research being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.
Postmenopausal women with clogged arteries are at higher risk of heart attacks than men of similar age, according to research presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC), and published in European Heart Journal—Cardiovascular Imaging.
A study published this week in the Journal of the American College of Cardiology (JACC) has found that over more than 20 years, seven major cardiovascular societies were more likely to distribute awards to men and white individuals compared to women and those who identify as Asian, Hispanic/Latino, and Black.
To learn more about this important field of cardiovascular clinical research, I invited Dr. Gregg Stone on the podcast. Stone has been recognized in Nature Medicine as one of the most prolific authors in science, and by the Web of Science as among the top 0.01% of cited researchers in science.
A healthy diet is associated with greater physical fitness in middle-aged adults, according to research published today in the European Journal of Preventive Cardiology.
Dr. Biering-Sørensen is professor and head of the Center for Translational Cardiology and Pragmatic Randomized Trials at the University of Copenhagen and head of the Cardiovascular Non-Invasive Imaging Research Laboratory at Copenhagen University Hospital – Herlev and Gentofte. Join the online meeting.
COVID-19 is associated with higher risks of cardiovascular disease and death in the short- and long-term, according to a study in nearly 160,000 participants published today in Cardiovascular Research, a journal of the European Society of Cardiology (ESC).
An automated system that flags which patients could most benefit from an underused yet life-saving cardiology drug more than doubled new prescriptions, according to a pilot program test by researchers at NYU Grossman School of Medicine.
The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC). A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart's ability to contract properly.
Their study is published as a Research Letter in the Canadian Journal of Cardiology. Investigators found that there is a marked lack of diversity in the mannikins depicted by public social media accounts of organizations that administer cardiopulmonary (CPR) education.
The findings highlight the need for better integration of patient-reported health data into pragmatic research studies. Results of the study were published in JAMA Cardiology. However, little information is available about the fitness for use of patient-reported data in large-scale health research.
… Pfizer told employees it plans to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies , Barron’s reports.
Smidt Heart Institute Chair of Cardiology presents new findings at American Heart Association Scientific Sessions Credit: Photo by Cedars-Sinai LOS ANGELES (Nov.
By integrating biomarker analysis into clinical trials, researchers can reduce costs, minimize trial durations, and improve the likelihood of delivering innovative therapies to patients more rapidly and effectively. Moreover, they facilitate regulatory approvals by providing robust, evidence-based data that aligns with stringent requirements.
times as likely to prescribe mineralocorticoid receptor antagonists (MRAs), a guideline-recommended class of heart failure medication, compared with doctors who did not receive such alerts, according to research being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.
This includes new Phase III trial data for Kerendia (finerenone) in patients with heart failure that was presented recently at this year’s European Society of Cardiology (ESC) Congress 2024. Tune into the episode to hear more about the latest trial data for finerenone in heart failure and the landscape of heart failure research.
Researchers from Mass General Brigham and collaborating institutions have developed a non-invasive approach to manipulate cardiac tissue activity by using light to stimulate an innovative ink incorporated into bioprinted tissue. Their goal is to develop a technique that can be used to repair the heart.
High fitness levels attenuate, but do not eliminate, the increased risk for cardiovascular mortality in men with high blood pressure, according to a research letter published online March 23 in the European Journal of Preventive Cardiology.
Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without severe infection, according to research presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).
Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according to research presented at ESC Preventive Cardiology 2023 and published in the International Journal of Environmental Research and Public Health.
Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice.
The ground-breaking research is presented today at Frontiers in CardioVascular Biomedicine 2022, a scientific congress of the European Society of Cardiology (ESC).1 Budapest, Hungary – 30 April 2022: A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack.
In patients with a poorly functioning tricuspid valve in the heart, a minimally invasive procedure using a clip to repair the valve was safe and improved both the valve's functioning and patients' quality of life at one year compared with the best available medical therapy but did not show any significant difference in survival or heart failure hospitalization, (..)
Researchers also need to ask what is the optimal CTA intervention and should downstream care be required? There are considerations for the flexibility of the intervention. When we evaluate imaging strategies for chest pain, is “usual testing” the appropriate comparator? Coronary CT angiography (CTA) may be the preferred test.
Sophia Antipolis – 29 June 2021: Heart attacks during the COVID-19 pandemic were more likely to result in heart failure compared with heart attacks one year earlier, according to research presented today at Heart Failure 2021, an online scientific congress of the European Society of Cardiology (ESC).1
Researchers at the University of Colorado School of Medicine have discovered a new mechanism for slowing scarring of heart tissue—a process known as cardiac fibrosis.
The Strategically Focused Research Network (SFRN) on Obesity has published its findings in a Journal of the American Heart Association special report, which hails the group's work as "the beginning of innovative science, and importantly, the birth of new collaborations and research partnerships to propel the field forward."
Further efforts are urgently needed to increase diversity in the cardiology workforce, which will improve clinical trial diversity and cardiovascular health for all. Globally cardiovascular disease (CVD) prevalence had decreased between 1990 and 2010, but it has slightly increased since 2010. CVD is the leading cause of mortality in women.
Madrid, Spain – 21 May 2022: Life-threatening arrhythmias are more common on days with highly polluted air, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1
Madrid, Spain – 22 May 2022: Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1
People hospitalized with COVID-19 may have an increased risk for heart damage, but not so much the type of inflammation previous research suggested, according to a new study.
. – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care, sleep medicine and related disciplines.
Researchers from the Cardiology Department at the University Medical Center Mainz have now discovered that noise exposure (average sound pressure level 72 dB; peak level 85 dB) up to 4d resulted in pro-inflammatory aortic gene expression in mice.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content